GL1X · GenesisL1 explorer

Research workbench

Crystal structure of protac 1 in complex with the bromodomain of human SMARCA2 and PVHL:ELONGINC:ELONGINB

Analyse Crystal structure of protac 1 in complex with the bromodomain of human SMARCA2… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6HAY
Type
protein
Length
930 residues
Chains
8
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Probable global transcription activator SNF2L2; Von hippel-lindau disease tumor…
EC
3.6.4.-
UniProt
P51531, P40337, Q15369, Q15370
Ligands
FX8
Pockets
10 · best druggability 0.68

Structure

x-ray diffraction · 8 distinct chains · 38% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProbable global transcription activator SNF2L2 (EC 3.6.4.-)protein12064% helix, 2% strandP51531
BVon hippel-lindau disease tumor suppressorprotein15226% helix, 28% strandP40337
CElongin-Cprotein9741% helix, 13% strandQ15369
DElongin-Bprotein10421% helix, 38% strandQ15370
EProbable global transcription activator SNF2L2 (EC 3.6.4.-)protein11564% helix, 2% strandP51531
FVon hippel-lindau disease tumor suppressorprotein15126% helix, 28% strandP40337
GElongin-Cprotein8848% helix, 15% strandQ15369
HElongin-Bprotein10315% helix, 39% strandQ15370

Ligands and binding sites

  • FX8 · (2~{S},4~{R})-~{N}-[[2-[2-[2-[2-[4-[3-azanyl-6-(2-hydroxyphenyl)pyridazin-4-yl]piperazin-1-yl]ethoxy]ethoxy]ethoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-1-[(2~{S})-2-[(1-fluoranylcyclopropyl)carbonylamino]-3,3-dimethyl-butanoyl]-4-oxidanyl-pyrrolidine-2-carboxamide · ligand · 2 copies · chains A, B, E, F
  • EDO · 1,2-ethanediol · additive · 22 copies · chains B, C, A, D, F, G, E, H
  • FMT · Formic acid · additive · chains B
  • EPE · 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid · additive · chains F, G

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

10 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14300.680.8046FX8, EDO
24320.660.7842FX8, EDO
32280.570.7949empty
4840.530.8524empty
52300.480.7435EDO

Interfaces

12 interfaces between chains.

  • C–D · 1145 Ų buried · 12 hydrogen bonds · protein-protein
  • G–H · 1142 Ų buried · 14 hydrogen bonds · protein-protein
  • F–G · 1109 Ų buried · 13 hydrogen bonds · protein-protein
  • B–C · 1092 Ų buried · 14 hydrogen bonds · protein-protein
  • B–F · 823 Ų buried · 11 hydrogen bonds · protein-protein

Compared structures

  • 6HAY · Crystal structure of PROTAC 1 in complex with the bromodomain of human SMARCA2 and… · the same entry in another collection · chain H against H, TM-score 1.00
  • Q15370 · AlphaFold monomer V2.0 prediction for elongin-B (Q15370) · a predicted model of the same protein · chain H against A, TM-score 0.99
  • Q15369 · AlphaFold monomer V2.0 prediction for elongin-C (Q15369) · a predicted model of the same protein · chain G against A, TM-score 0.98
  • P51531 · AlphaFold monomer V2.0 prediction for probable global transcription activator SNF2L2… · a predicted model of the same protein · chain E against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.